Daclatasvir plus sofosbuvir for HCV infection

N Engl J Med. 2014 Apr 17;370(16):1560. doi: 10.1056/NEJMc1401726.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Uridine Monophosphate / analogs & derivatives*
  • Viral Nonstructural Proteins / antagonists & inhibitors*

Substances

  • Antiviral Agents
  • Imidazoles
  • Viral Nonstructural Proteins
  • Uridine Monophosphate